RxDoctor Payments Data

Gregory Kato

Pediatric Hematology-Oncology · Bethesda, MDNPI 1578504767

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,660 of the $10,311 with a category attached, or 64.6%. Novartis accounts for 90.4% of it on its own, with 1 other manufacturer making up the rest. Among pediatric hematology-oncology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,311in general payments, 2019–2025

Across 21 payments — averaging $491.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$9K
  • CSL Behring$992
$2,962,166in research payments, 2019–2025

Across 8 payments — averaging $370,271 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bayer$3M
  • Novartis$327

What the payments were for

  • Consulting fees$6,66065%
  • Travel & lodging$2,99729%
  • Food & beverage$6546%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis13$9,320
CSL Behring8$992

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,311 in reported general payments places this provider in the 90th percentile of 52 pediatric hematology-oncology providers in Maryland.

See all pediatric hematology-oncology providers in Maryland

Other pediatric hematology-oncology in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →